EchoLaser on Corriere della Sera
Elesta EchoLaser has been featured on Corriere della Sera, number one newspaper in Italy by circulation and readership.
Its urology application for the treatment of BPH symptoms is TPLA (transperineal laser ablation), aka SoracteLite.
It is a novel technique which is gaining fast adoption internationally. Safety and efficacy profile was confirmed by many publications, which include two RCT’s vs TURP and one systematic review. Despite new, durability data on this treatment modality at 2 and 3 years are also published (5 years data coming soon).
Link to the article: https://www.corriere.it/salute/sportello_cancro/24_aprile_01/ipertrofia-della-prostata-quando-operare-e-quali-sono-le-tecniche-piu-indicate-a-seconda-anche-dell-eta-29c017e9-d1a3-49a7-abf7-cfe11e525xlk.shtml
Corso Teorico Pratico all’LXY Institute di MADRID!
Si è concluso il corso teorico – pratico al LXY Institute di Madrid, dove EchoLaser TPLA ha svolto un ruolo centrale come trattamento per l’IPB.
Scopri di più grazie al Dr. Pablo Garrido Abad!
III Edición Curso Práctico en STUI y Patología Vesicoprostática basado en Simulación
Echolaser: la prima scelta
Wonderful Donations In UK
We are thrilled to announce the successful delivery of an EchoLaser TPLA to The Royal Surrey County Hospital, made possible by the generous donation from The Prostate Project. This cutting-edge medical equipment will provide new treatment options for patients suffering from benign prostatic hyperplasia (BPH) within the NHS system.
This achievement marks a significant step forward in advancing medical technology in the UK, and we look forward to the positive impact it will have on patients’ lives.
Learn more about our mission to improve patient outcomes and advance healthcare innovation at www.elesta-echolaser.com.
https://www.royalsurrey.nhs.uk/news/echo-laser-machine-to-treat-prostate-enlargement-10388